JCP

eISSN 2288-3657
pISSN 2288-3649

Table 6 Evaluation of ER, PR, and HER2 using endpoint RT-PCR (n = 41)

Variable	Endpoint RT-PCR	Frequency
ER	Positive	29 (70.7)
	Negative	12 (29.3)
PR	Positive	5 (12.2)
	Negative	36 (87.8)
HER2	Positive	9 (22.0)
	Negative	32 (78.0)

Values are presented as number (%). RT-PCR, reverse transcription PCR; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2.

J Cancer Prev 2023;28:64~74 https://doi.org/10.15430/JCP.2023.28.2.64